Evonik gains on report BASF increased offer for Evonik to over €11B (EVKIF:OTCMKTS)
Evonik's shares rose 5.2% after BASF reportedly increased its bid to over €11B ($12.3B), offering around €24 per share. Both companies are German chemicals firms.
How this was made
The 30-second read
Why it matters
The announcement immediately moved Evonik shares up 5.2% and introduces acquisition risk for BASF, affecting sector sentiment.
Market read
A material takeover bid with a €11 bn valuation, prompting immediate price action and sector‑wide implications.
What to watch
Regulatory approval risk in the EU and potential antitrust hurdles could delay or block the deal.
Background
The article reports a fresh, higher bid by BASF for Evonik, marking a significant M&A development in the European chemicals industry.
Ticker impact
Evonik shares rose 5.2% in Frankfurt after news BASF raised its bid to over €11 billion.
upward pressure on Evonik as investors price in a potential takeover premium
The bid is a fresh, material offer exceeding €11 bn and triggered an immediate price move.
Market effects
European chemicals sector may see consolidation pressure and valuation adjustments.
German market likely to react with heightened volatility in chemical stocks.
Large‑cap European chemicals players could see ripple effects in global commodity pricing.
Counterpoint
The bid may be overvalued; BASF could face financing constraints, leading to a pull‑back.
Key entities
- CompanyEvonik Industries AG
German chemicals producer, target of the bid.
- CompanyBASF SE
European chemicals giant, making the acquisition offer.
